Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2021

  1. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

  2. Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

    Translational Research, Vol. 188, pp. 80-91.e2

2016

  1. Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue

    Stem Cell Research, Vol. 16, Núm. 1, pp. 20-23

2011

  1. MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia

    Cell Transplantation, Vol. 20, Núm. 2, pp. 259-269

2010

  1. Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and-resistant Bcr-Abl1-expressing cells

    Oncogene, Vol. 29, Núm. 22, pp. 3276-3286

2008

  1. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

    Leukemia Research, Vol. 32, Núm. 5, pp. 709-716

2006

  1. Somatic stem cells and the origin of cancer

    Clinical and Translational Oncology, Vol. 8, Núm. 9, pp. 647-663